Company intelligence / Profile preview

Nereid Therapeutics

Cambridge, Massachusetts, United Statesnereidtx.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Nereid is developing technologies to visualize and measure liquid-liquid phase separation in cells and discover small molecules that can modulate protein interactions in disease states. The company has demonstrated translatability of chemical matter that modulates LLPS behavior to disease-relevant cellular phenotypes and is progressing several programs in cancer and other diseases.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Small molecules
Industry: Biotech

Beyond the preview

Go deeper on Nereid Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nereid Therapeutics.

Explore the full profile